Keymed Biosciences Co.Ltd
Keymed Biosciences Co.Ltd
Explore linked clinical trials.28 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of CM583 in Healthy Participants | Healthy | Not yet recruiting | Phase 1 | 2026-09-16 | NCT07823764 | |
| BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma | High Risk Smoldering Multiple Myeloma | Recruiting | Not applicable | 2026-07-23 | NCT06745687 | |
| A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-2） | Chronic Rhinosinusitis With Nasal Polyposis | Not yet recruiting | Phase 2 | 2026-06-30 | NCT07519577 | |
| Study of CM518D1 in Patients With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-06-15 | NCT07019779 | |
| CM336 for Active Sjogren's Syndrome Study | Primary Sjögren's Syndrome (pSS) | Not yet recruiting | Phase 1 | 2026-06-12 | NCT07642843 | |
| Finotonlimab Combined With Stapokibart in the Treatment of Recurrent/Metastatic HNSCC | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Recruiting | Phase 1 | 2026-05-04 | NCT07040072 | |
| Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU) | Chronic Disease, Disease Attributes, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, chronic urticaria, immune system disorder, skin disorder, skin vascular disease, urticaria | Recruiting | Phase 2 | 2026-04-09 | NCT07166211 | |
| Study of CM383 in Healthy Subjects | Healthy | Recruiting | Phase 1 | 2026-01-23 | NCT07292688 | |
| A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia | Cytopenia, Evans syndrome, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, anemia, autoimmune disease, autoimmune hemolytic anemia, blood coagulation disease, blood platelet disease, hematologic disorder, hemolytic anemia, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy | Recruiting | Phase 1 / Phase 2 | 2025-12-17 | NCT07175493 | |
| Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis | Primary Light-Chain Amyloidosis | Recruiting | Phase 2 | 2025-11-26 | NCT07039578 | |
| A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis. | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 2 | 2025-11-17 | NCT07230483 | |
| Study of CM310 in Adolescent Subjects With Atopic Dermatis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Active, not recruiting | Phase 3 | 2025-10-02 | NCT06495229 | |
| Study of CM559 in Healthy Subjects | Healthy Subjects | Recruiting | Phase 1 | 2025-09-29 | NCT07175506 | |
| Study of CM313 in Subject With IgA Nephropathy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Not yet recruiting | Phase 2 | 2025-09-19 | NCT06830395 | |
| Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Not yet recruiting | Phase 3 | 2025-09-18 | NCT07181239 | |
| Study of CM512 Injection in Subjects With Moderate-to-severe Asthma | Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 2 | 2025-08-28 | NCT07011524 | |
| Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 2 | 2025-08-17 | NCT06947980 | |
| Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness | Platelet Transfusion Refractoriness | Recruiting | Phase 1 / Phase 2 | 2025-08-15 | NCT06792019 | |
| A Study of Stapokibatrt in Children Subjects With Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Not yet recruiting | Phase 3 | 2025-08-06 | NCT07106372 | |
| A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary Disease | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Not yet recruiting | Phase 2 | 2025-05-20 | NCT06980142 | |
| Study of Stapokibatrt in Children Subjects With Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Not yet recruiting | Phase 3 | 2025-05-04 | NCT06956196 | |
| A Study of CM350 in Patients With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2025-05-04 | NCT05263960 | |
| Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP) | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy | Active, not recruiting | Phase 2 | 2025-04-23 | NCT06594146 | |
| A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 1 | 2025-03-19 | NCT06619613 | |
| Study of CM313(SC) Injection in Subjects With Relapsed/Refractory Aplastic Anemia | Bone Marrow Failure Disorders, Hemic and Lymphatic Diseases, anemia, aplastic anemia, bone marrow disorder, hematologic disorder | Not yet recruiting | Phase 1 / Phase 2 | 2025-02-18 | NCT06791824 |